A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. Europe...

por Dieras, V., Chevallier, B., Kerbrat, P., Krakowski, I., Roche, H., Misset, J. L., Lentz, M. A., Azli, N., Murawsky, M., Riva, A., Pouillart, P., Fumoleau, P.
Publicado 1996

Participants’ uptake of clinical trial results: a randomised experiment

por Mancini, J, Genre, D, Dalenc, F, Ferrero, J-M, Kerbrat, P, Martin, A-L, Roché, H, Maylevin, F, Tarpin, C, Viens, P, Genève, J, Julian-Reynier, C
Publicado 2010

Ovarian cancer

por Kerbrat, P, Lhommé, C, Fervers, B, Guastalla, J P, Thomas, L, Tournemaine, N, Basuyau, J P, Cohen-Solal, C, Duvillard, P, Bachelot, T, Ray, I, Voog, E, Dauplat, J
Publicado 2001

Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial

por Kerbrat, P, Roché, H, Bonneterre, J, Veyret, C, Lortholary, A, Monnier, A, Fumoleau, P, Fargeot, P, Namer, M, Chollet, P, Goudier, M-J, Audhuy, B, Simon, H, Montcuquet, P, Eymard, J-C, Walter, S, Clavère, P, Guastalla, J-P
Publicado 2007